The use of contraception by women is common. Birth control pills and other hormonal methods are used by millions of women around the world. The need to evaluate the influence of these methods on the genesis of the breast tumor is clear.
- 11.Massarotti C, et al. State of the art on oocyte cryopreservation in female cancer patients: a critical review of the literature. Cancer Treat Rev. 2017;57:50–7. Studies evaluating the efficiency of egg freezing. INTERPRETATION: Freezing of eggs is a promising technique, but results are still lower than results on embryo freezing. CrossRefGoogle Scholar
- 12.Moorman PG, et al. Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol. 2013;31(33):4188–98. Four studies (cohort, control case and a meta-analysis) that evaluated BRCA1 or 2 mutation carriers and the use of oral contraceptives are discussed here. INTERPRETATION: In BRCA1 or 2 mutation carriers, oral contraception may increase the risk of breast cancer. CrossRefGoogle Scholar
- 15.Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23:4347. Studies evaluating the efficacy of letrozole and tamoxifen for ovarian stimulation. INTERPRETATION: Letrozole and tamoxifen are valid options for ovarian stimulation and embryo freezing. CrossRefGoogle Scholar
- 17.Samson M, Porter N, Orekoya O, Hebert JR, Adams SA, Bennett CL, Steck SE. Progestin and breast cancer risk: a systematic review. Breast Cancer Res Treat. 2016;155(1):3–12. https://doi.org/10.1007/s10549-015-3663-1. Epub 2015 Dec. The first three studies are epidemiological studies. The first one (Hannaford et al.) with nearly 50,000 women followed on average for 24 years. The incidence of breast cancer was similar in users and non-users of pills. The fifth indicates otherwise. The fourth, sixth and seventh ones are more recent meta-analyses. The fourth one concludes that oral contraceptives are not related to breast tumor deaths. The sixth study assesses the risk of oral contraceptives and concludes a small increase in risk. The seventh one indicates that progesterone-only formulations do not increase the risk of breast tumor. INTERPRETATION: This subject is still controversial, but it is known that combined oral contraceptives could increase the risk of breast tumor. CrossRefPubMedGoogle Scholar
- 18.Taylan E, Oktay KH. Current state and controversies in fertility preservation in women with breast cancer. World J Clin Oncol. 2017;8(3):241–8. Randomized study evaluating the effect of GnRH agonist on preservation of fertility in patients submitted to neoadjuvant chemotherapy for breast tumor, and review on the subject. INTERPRETATION: Ovary blockade with GnRH agonist has no proven benefit for preservation of fertility in patients undergoing chemotherapy. CrossRefGoogle Scholar
- 20.Veeck LL, Bodine R, Clarke RN, et al. High pregnancy rates can be achieved after freezing and thawing human blastocysts. Fertil Steril. 2004;82:1418. Pieces of work comparing the rate of implantation of fresh and frozen embryos and revision. INTERPRETATION: Embryo freezing methods are effective at implantation rates similar to unfrozen embryos. CrossRefGoogle Scholar
© Springer Nature Switzerland AG 2019